Navigation Links
BNY Mellon Appointed as Depositary by Mazor Robotics Ltd.
Date:6/10/2013

NEW YORK, June 10, 2013 /PRNewswire/ -- BNY Mellon, the global leader in investment management and investment services, has been appointed by Mazor Robotics Ltd. as depositary bank for its American depositary receipt (ADR) program. Each Mazor Robotics ADR represents two ordinary shares and trades on NASDAQ under the symbol "MZOR." Mazor Robotics' ordinary shares trade on the Tel Aviv Stock Exchange under the symbol "MZOR."

Mazor Robotics develops innovative surgical guidance systems and complementary products in the spinal surgery market that have been used in more than 35,000 implants in the U.S., Asia and Europe. Its flagship product, Renaissance™, is a state-of-the-art system that enables surgeons to conduct spinal surgeries accurately. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability and clinical advantages of Mazor Robotics' technology.

"The momentum created by the successful market penetration of our Renaissance systems, coupled with the availability of our ADRs on NASDAQ, means U.S. investors will be able to share in our continued progress," commented Ori Hadomi, Mazor Robotics' president and CEO.

"Mazor's decision shows yet another Israeli company understanding the many benefits of DRs both for issuing companies and their investors abroad," said Christopher M. Kearns, CEO of BNY Mellon's Depositary Receipts business. "We believe their listing in the U.S. has the potential to widen Mazor's investor base dramatically."

BNY Mellon acts as depositary for more than 2,700 American and global depositary receipt programs, acting in partnership with leading companies from 68 countries. BNY Mellon is committed to helping securities issuers access the world's rapidly evolving financial markets and delivers a comprehensive suite of depositary receipt services. Learn more at www.bnymellon.com/dr

BNY Mellon is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle. Whether providing financial services for institutions, corporations or individual investors, BNY Mellon delivers informed investment management and investment services in 36 countries and more than 100 markets. As of March 31, 2013, BNY Mellon had $26.3 trillion in assets under custody and/or administration, and $1.4 trillion in assets under management. BNY Mellon can act as a single point of contact for clients looking to create trade, hold, manage, service, distribute or restructure investments. BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK). Learn more at bnymellon.com, or follow us on Twitter @BNYMellon

This release is for informational purposes only. BNY Mellon provides no advice nor recommendation or endorsement with respect to any company or securities. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities. Depositary Receipts: Not FDIC, State or Federal Agency Insured; May Lose Value; No Bank, State or Federal Agency Guarantee.


'/>"/>
SOURCE BNY Mellon
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Carnegie Mellons Christopher Bettinger Develops Edible Electronics for Medical Device Industry
2. Carnegie Mellon University Biomedical Engineers Lead Collaborative Team Developing New Astro Surgery Tools for NASA Deep Space Missions
3. Parents Less Likely To Develop Colds, Carnegie Mellon Research Shows
4. Rethinking Research Ethics: Carnegie Mellon and McGill Researchers Challenge Post-marketing Trial Practices
5. Randy Hill Appointed to Vasomedical Board of Directors
6. Lynn Kramer, MD, Appointed Chief Clinical Officer of Eisai Product Creation Systems
7. Ken Mulvany Appointed Chairman of The Cure Parkinsons Trust
8. David Norton Appointed to TB Alliances Board of Directors
9. Searcy Denney Scarola Barnhart & Shipley Attorney Appointed to Plaintiffs Steering Committee for Stryker Hip Implant Litigation
10. Graham Cooper Appointed Chief Financial Officer of Receptos
11. Gregory D. Cash Appointed President and Chief Executive Officer of NeuroTherm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
(Date:4/18/2017)... Ohio , April 18, 2017  Cardinal Health ... Non-GAAP 1 fiscal 2017 earnings per share (EPS) ... and 2019.  This is in conjunction with this morning,s ... Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... from continuing operations will be at the bottom of ...
(Date:4/18/2017)... 2017 Research and Markets has announced the ... to their offering. ... arthroscopy devices market to grow at a CAGR of 6.35% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
Breaking Medicine Technology:
(Date:4/21/2017)... PA (PRWEB) , ... April 21, 2017 , ... ... firm in Allegheny County that offers services to communities throughout the greater Pittsburgh ... in a charity drive to provide adaptive bicycles for differently-abled children. , Variety ...
(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, ... Advocacy Award in recognition of her extraordinary contributions to the field of patient ... Beryl Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... ... 21, 2017 , ... Crossover Symmetry , an evidence ... active lifestyle company that provides Human Performance Training and education to tactical athletes. ... responders, military officers and others in service through the development and conditioning of ...
(Date:4/21/2017)... ... 2017 , ... Airway Management, the medical device manufacturer of ... and well renowned Asian distributor, Discovery Sleep. The agreement involves the ... and will stabilize and strengthen Airway’s presence with a dedicated, reputable medical device ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... candidates to serve on its Accreditation and Standards Committees to support the ... is improving image quality and reducing patient radiation dose,” reports Eliot Siegel, ...
Breaking Medicine News(10 mins):